TRIGENESIS THERAPEUTICS

Trigenesis Therapeutics is a Biotechnology company.

#SimilarOrganizations #People #More

TRIGENESIS THERAPEUTICS

Industry:
Biotechnology Health Care Medical

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Status:
Active


Similar Organizations

capres-as-logo

Capres A/S

Capres develops micro and nanoscopic four point probe based metrology tools for the read head and semiconductor industry.

diagnostic-products-corporation-logo

Diagnostic Products Corporation

Diagnostic Products Corporation is a Biotechnology company.

epiaxis-therapeutics-logo

EpiAxis Therapeutics

EpiAxis Therapeutics is a Biotechnology company.

geneius-logo

Geneius

Geneius is a Biotechnology company.

genervon-biopharmaceuticals-logo

Genervon Biopharmaceuticals

Genervon Biopharmaceuticals is a biotechnology company.

longhorn-vaccines-diagnostics-logo

Longhorn Vaccines & Diagnostics

Longhorn Vaccines & Diagnostics is an Industry Leading Biotechnology Company

not_available_image

MassBiologics

MassBiologics is a Biotechnology company.

medical-metrics-logo

Medical Metrics

Medical Metrics is a Biotechnology company located in Houston.

quanta-biodesign-logo

Quanta BioDesign

The Quanta BioDesign dPEGยฎ product line is a unique technology platform.

stemsynergy-therapeutics-logo

StemSynergy Therapeutics

StemSynergy Therapeutics, Inc. (SSTI) is a biotechnology company.

Founder


neal-walker_image

Neal Walker

stephen-tullman_image

Stephen Tullman

More informations about "Trigenesis Therapeutics"

Trigenesis Therapeutics - PitchBook

Trigenesis Therapeutics General Information Description. Manufacturer of skin care products in the United States. The company offers a pipeline of differentiated drugs in the dermatology segments.See details»

Trigenesis Therapeutics - 2025 Company Profile - Tracxn

Trigenesis Therapeutics - Proprietary drug delivery technology platforms for developing a pipeline of differentiated drugs in the dermatology segment.. Acquired by Dr. Reddy's Laboratories. โ€ฆSee details»

Trigenesis Therapeutics, Inc. - VentureRadar

Trigenesis Therapeutics, Inc. VentureRadar profile. Find out more about Trigenesis Therapeutics, Inc. including the VentureRadar Innovation and Growth scores, Similar Companies and more. โ€ฆSee details»

Trigenesis Therapeutics acquired by Dr. Reddyโ€™s Laboratories

Trigenesis Therapeutics Trigenesis Therapeutics is a Biotechnology company. Acquiring Organization: Dr. Reddyโ€™s Laboratories Dr. Reddyโ€™s Laboratories is an integrated โ€ฆSee details»

Trigenesis Therapeutics Inc - Company Profile and News

Company profile page for Trigenesis Therapeutics Inc including stock price, company news, executives, board members, and contact informationSee details»

Trigenesis Therapeutics - LinkedIn

Trigenesis Therapeutics | 6 followers on LinkedIn.See details»

Trigenesis Therapeutics, Inc. - Drug pipelines, Patents, Clinical ...

Explore Trigenesis Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»

Trigenesis Therapeutics - Raised Funding from 1 investor - Tracxn

Dec 21, 2024 Trigenesis Therapeutics funding & investors. Proprietary drug delivery technology platforms for developing a pipeline of differentiated drugs in the dermatology segment. 2003 โ€ข โ€ฆSee details»

Trigenesis Therapeutics Inc. investors Company Profile Information ...

This section on investors provides comprehensive profiles of the founders, directors and investors of Trigenesis Therapeutics Inc.. The portal even gives details about the present investors as โ€ฆSee details»

TRIGENESIS THERAPEUTICS, INC. :: Delaware (US) - OpenCorporates

TRIGENESIS THERAPEUTICS, INC. Company Number 3492180 Incorporation Date 14 February 2002 (almost 21 years ago) Company Type Corporation Jurisdiction Delaware (US) Agent โ€ฆSee details»

Trigenesis Therapeutics - Updates, News, Events, Signals & Triggers

May 7, 2004 Trigenesis Therapeutics is a Biotechnology company. Business Wire โ€” NeXeption Forms New Company Velicept Therapeutics, Inc.; Intends to Merge with AltheRx โ€ฆSee details»

Trigenesis Therapeutics Inc Company Profile, Financial and

DigitGaps report on Trigenesis Therapeutics Inc delivers a detailed in-depth and comprehensive insights of the company, its history, corporate strategy, its businesses and structures, and โ€ฆSee details»

Trigenesis Therapeutics - Products, Competitors, Financials, โ€ฆ

Trigenesis Therapeutics is a US based privately owned dermatology company. On May 6, 2004, Trigenesis Therapeutics was acquired by Dr. Use the CB Insights Platform to explore โ€ฆSee details»

Trigenesis Therapeutics Inc. team Company Profile Information ...

A deep-dive into the profiles of the top leaders and torchbearers of the organization in Trigenesis Therapeutics Inc.. The platform also tracks the board members and directors of the company, โ€ฆSee details»

Trigenesis Therapeutics - Crunchbase

Trigenesis Therapeutics is a Biotechnology company. Start Free Trial . Chrome ExtensionSee details»

Dr Reddy's buys US firm Trigenesis - Business Standard

May 6, 2004 Dr Reddy's Laboratories has acquired Trigenesis Therapeutics Inc, a US-based dermatology company, in an $11 million all cash deal. The deal is significant because it โ€ฆSee details»

Trigenesis Therapeutics Inc. key_developments Company Profile ...

Get latest updates and key developments in Trigenesis Therapeutics Inc. as a part of this platform. The section entails noteworthy news, announcements and disclosures made by โ€ฆSee details»

Trigenesis Therapeutics founders & board of directors - Tracxn

Mar 23, 2025 Trigenesis Therapeutics's founders include Osagie Imasogie and Steve Tullman.See details»

Trigenesis Therapeutics - Company Profile - Tracxn

Trigenesis Therapeutics - Proprietary drug delivery technology platforms for developing a pipeline of differentiated drugs in the dermatology segment.. Acquired by Dr. Reddy's Laboratories. โ€ฆSee details»

New study results reinforce Tagrisso as the backbone therapy for โ€ฆ

Mar 25, 2025 New study results presented at the European Lung Cancer Congress (ELCC) 2025, 26 to 29 March, demonstrate the role of AstraZenecaโ€™s Tagrisso (osimertinib), as โ€ฆSee details»

linkstock.net © 2022. All rights reserved